Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 49, 2014, Pages E5302-E5311

  Chan, Rebecca W Y ^a,b   Jiang, Peiyong ^a,b   Peng, Xianlu ^a,b   Tamc, Lai Shan ^b   Liao, Gary J W ^a,b   Li, Edmund K M ^b   Wong, Priscilla C H ^b   Sun, Hao ^a,b   Chan, K C Allen ^a,b   Chiu, Rossa W K ^a,b   Dennis Lo, Y M ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autoimmune disease; Epigenetics; Genomic representation; Massively parallel sequencing; Size profiling

Indexed keywords

DNA; IMMUNOGLOBULIN G; PROTEIN G; BIOLOGICAL MARKER;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ABERRATION; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE DOSAGE; GENE SEQUENCE; GENETIC DISORDER; HUMAN; HUMAN GENOME; MOLECULAR SIZE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; AGED; BLOOD; CHROMOSOME ABERRATION; CPG ISLAND; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETIC EPIGENESIS; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED;

ADULT; AGED; BIOMARKERS; CHROMOSOME ABERRATIONS; CPG ISLANDS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENE LIBRARY; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEQUENCE ANALYSIS, DNA;

EID: 84917709441     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1421126111     Document Type: Article

References (47)

1. Gladman DD, Urowitz MB (2007) Prognosis, mortality and morbidity in systemic lupus erythematosus. Dubois' Lupus Erythematosus, eds Wallace DJ, Hahn BH (Lippincott Williams & Wilkins, Philadelphia), 7th Ed, pp 1333-1353.
2. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110-2121.
3. Cervera R, et al.; European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1, 000 patients. Medicine (Baltimore) 82(5):299-308.
4. Rullo OJ, Tsao BP (2013) Recent insights into the genetic basis of systemic lupus er-ythematosus. Ann Rheum Dis 72(Suppl 2):ii56-ii61.
5. Pisetsky DS (2004) The immune response to cell death in SLE. Autoimmun Rev 3(7-8): 500-504.
6. Su KY, Pisetsky DS (2009) The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol 70(3):175-183.
7. Emlen W, Niebur J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152(7):3685-3692.
8. Munoz LE, et al. (2005) SLE-A disease of clearance deficiency? Rheumatology (Oxford) 44(9):1101-1107.
9. Sallai K, Nagy E, Derfalvy B, Müzes G, Gergely P (2005) Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus er-ythematosus. Clin Diagn Lab Immunol 12(1):56-59.
10. Strickland FM, Richardson BC (2008) Epigenetics in human autoimmunity. Epigenetics in autoimmunity-DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity 41(4):278-286.
11. Richardson B, et al. (1990) Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33(11): 1665-1673.
12. Ballestar E, Esteller M, Richardson BC (2006) The epigenetic face of systemic lupus erythematosus. J Immunol 176(12):7143-7147.
13. Yang ML, et al. (2013) Lupus autoimmunity altered by cellular methylation metabolism. Autoimmunity 46(1):21-31.
14. Wen ZK, et al. (2007) DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46(12):1796-1803.
15. Tan EM, Schur PH, Carr RI, Kunkel HG (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45(11):1732-1740.
16. Raptis L, Menard HA (1980) Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66(6):1391-1399.
17. Chen JA, et al. (2007) Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus. Autoimmunity 40(4):307-310.
18. Rumore PM, Steinman CR (1990) Endogenous circulating DNA in systemic lupus er-ythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 86(1):69-74.
19. Chiu RWK, et al. (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneu-ploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105(51):20458-20463.
20. Lo YMD, et al. (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2(61):61ra91.
21. Palomaki GE, et al. (2011) DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 13(11):913-920.
22. Beck J, Urnovitz HB, Mitchell WM, Schütz E (2010) Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res 8(3):335-342.
23. Leary RJ, et al. (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4(162):162ra154.
24. Chan KCA, et al. (2013) Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA 110(47):18761-18768.
25. Chan KCA, et al. (2013) Cancer genome scanning in plasma: Detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 59(1):211-224.
26. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; The Committee on Prognosis Studies in SLE (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35(6):630-640.
27. Krzywinski M, et al. (2009) Circos: An information aesthetic for comparative ge-nomics. Genome Res 19(9):1639-1645.
28. Zheng YWL, et al. (2012) Nonhematopoietically derived DNA is shorter than hema-topoietically derived DNA in plasma: A transplantation model. Clin Chem 58(3):549-558.
29. Lun FMF, et al. (2013) Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 59(11):1583-1594.
30. Arbuckle MR, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526-1533.
31. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A (2007) Fifty years of anti-ds DNA antibodies: Are we approaching journey's end? Rheumatology (Oxford) 46(7):1052-1056.
32. Winfield JB, Faiferman I, Koffler D (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 59(1): 90-96.
33. Haakenstad AO, Mannik M (1974) Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol 112(5):1939-1948.
34. Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH (1979) Defective re-ticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300(10):518-523.
35. Mir A, Porteu F, Levy M, Lesavre P, Halbwachs-Mecarelli L (1988) C3b receptor (CR1) on phagocytic cells from SLE patients: Analysis of the defect and familial study. Clin Exp Immunol 73(3):461-466.
36. Uccellini MB, et al. (2008) Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol 181(9):5875-5884.
37. Uccellini MB, Busto P, Debatis M, Marshak-Rothstein A, Viglianti GA (2012) Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence. Immunol Lett 143(1):85-91.
38. Chiu RWK, et al. (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342:c7401.
39. Yu SCY, et al. (2014) Size-based molecular diagnostics using plasma DNA for non-invasive prenatal testing. Proc Natl Acad Sci USA 111(23):8583-8588.
40. Kelly TK, et al. (2012) Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res 22(12):2497-2506.
41. Anker P, Stroun M, Maurice PA (1976) Spontaneous extracellular synthesis of DNA released by human blood lymphocytes. Cancer Res 36(8):2832-2839.
42. Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR (1972) Excretion of deoxy-ribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci USA 69(7):1685-1689.
43. Lei W, et al. (2009) Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38(5):369-374.
44. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q (2013) Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 41:92-99.
45. Tsui NBY, et al. (2012) High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing. PLoS ONE 7(10):e48319.
46. Li R, et al. (2009) SOAP2: An improved ultrafast tool for short read alignment. Bio-informatics 25(15):1966-1967.
47. Jiang P, et al. (2014) Methy-Pipe: An integrated bioinformatics pipeline for whole genome bisulfite sequencing data analysis. PLoS ONE 9(6):e100360.